These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


146 related items for PubMed ID: 2456047

  • 1. Cerebrospinal fluid and urinary biogenic amines in depressed patients and healthy controls.
    Davis JM, Koslow SH, Gibbons RD, Maas JW, Bowden CL, Casper R, Hanin I, Javaid JI, Chang SS, Stokes PE.
    Arch Gen Psychiatry; 1988 Aug; 45(8):705-17. PubMed ID: 2456047
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Biogenic amine and metabolite levels in depressed patients with high versus normal hypothalamic-pituitary-adrenocortical activity.
    Stokes PE, Maas JW, Davis JM, Koslow SH, Casper RC, Stoll PM.
    Am J Psychiatry; 1987 Jul; 144(7):868-72. PubMed ID: 2440319
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pretreatment neurotransmitter metabolite levels and response to tricyclic antidepressant drugs.
    Maas JW, Koslow SH, Katz MM, Bowden CL, Gibbons RL, Stokes PE, Robins E, Davis JM.
    Am J Psychiatry; 1984 Oct; 141(10):1159-71. PubMed ID: 6207736
    [Abstract] [Full Text] [Related]

  • 6. Day-to-day intraindividual reliability and interindividual differences in monoamines excretion.
    Curtin F, Walker JP, Schulz P.
    J Affect Disord; 1996 Jun 05; 38(2-3):173-8. PubMed ID: 8791186
    [Abstract] [Full Text] [Related]

  • 7. Selective antidepressants and cerebrospinal fluid. Lack of specificity on norepinephrine and serotonin metabolites.
    Potter WZ, Scheinin M, Golden RN, Rudorfer MV, Cowdry RW, Calil HM, Ross RJ, Linnoila M.
    Arch Gen Psychiatry; 1985 Dec 05; 42(12):1171-7. PubMed ID: 2416297
    [Abstract] [Full Text] [Related]

  • 8. Tricyclic antidepressant washout effects on cerebrospinal fluid and urinary monoamine and metabolites.
    Koslow SH, Maas JW, Bowden CL, Davis JM, Hanin I, Javaid J.
    Arch Gen Psychiatry; 1986 Oct 05; 43(10):1012-3. PubMed ID: 2428327
    [No Abstract] [Full Text] [Related]

  • 9. Biogenic amine metabolism in Tourette syndrome.
    Butler IJ, Koslow SH, Seifert WE, Caprioli RM, Singer HS.
    Ann Neurol; 1979 Jul 05; 6(1):37-9. PubMed ID: 292354
    [Abstract] [Full Text] [Related]

  • 10. Lower CSF homovanillic acid levels in depressed patients with a history of alcoholism.
    Sher L, Oquendo MA, Li S, Huang YY, Grunebaum MF, Burke AK, Malone KM, Mann JJ.
    Neuropsychopharmacology; 2003 Sep 05; 28(9):1712-9. PubMed ID: 12825091
    [Abstract] [Full Text] [Related]

  • 11. High correlations of norepinephrine, dopamine, and epinephrine and their major metabolite excretion rates.
    Linnoila M, Oliver J, Adinoff B, Potter WZ.
    Arch Gen Psychiatry; 1988 Aug 05; 45(8):701-4. PubMed ID: 3395200
    [Abstract] [Full Text] [Related]

  • 12. Cerebrospinal fluid amine metabolites. Relationships with behavioral measurements in depressed, manic, and healthy control subjects.
    Redmond DE, Katz MM, Maas JW, Swann A, Casper R, Davis JM.
    Arch Gen Psychiatry; 1986 Oct 05; 43(10):938-47. PubMed ID: 2428328
    [Abstract] [Full Text] [Related]

  • 13. Monoamine metabolites in cerebrospinal fluid of depressive subgroups.
    Rosenthal NE, Davenport Y, Cowdry RW, Webster MH, Goodwin FK.
    Psychiatry Res; 1980 Mar 05; 2(1):113-9. PubMed ID: 6158064
    [Abstract] [Full Text] [Related]

  • 14. Urinary catecholamine metabolites in hyperkinetic boys treated with d-amphetamine.
    Shekim WO, Dekirmenjian H, Chapel JL.
    Am J Psychiatry; 1977 Nov 05; 134(11):1276-9. PubMed ID: 910984
    [Abstract] [Full Text] [Related]

  • 15. Urinary noradrenaline and serotonin metabolites in drug-free Parkinson patients and the effect of L-dopa treatment.
    Markianos M, Hadjikonstantinou M, Bistolaki E.
    Acta Neurol Scand; 1982 Aug 05; 66(2):267-75. PubMed ID: 6182730
    [Abstract] [Full Text] [Related]

  • 16. High intercorrelations among urinary outputs of norepinephrine and its major metabolites. A replication in depressed patients and controls.
    Roy A, Guthrie S, Karoum F, Pickar D, Linnoila M.
    Arch Gen Psychiatry; 1988 Feb 05; 45(2):158-61. PubMed ID: 3337613
    [Abstract] [Full Text] [Related]

  • 17. Effects of amitriptyline and imipramine on brain amine neurotransmitter metabolites in cerebrospinal fluid.
    Bowden CL, Koslow SH, Hanin I, Maas JW, Davis JM, Robins E.
    Clin Pharmacol Ther; 1985 Mar 05; 37(3):316-24. PubMed ID: 2578912
    [Abstract] [Full Text] [Related]

  • 18. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M.
    Med Biol; 1985 Mar 05; 63(1):1-17. PubMed ID: 2582215
    [Abstract] [Full Text] [Related]

  • 19. Monoamine metabolites in ventricular CSF of children with posterior fossa tumors: correlation with tumor histology and cognitive functioning.
    Varela M, Alexiou GA, Liakopoulou M, Papakonstantinou E, Pitsouni D, Alevizopoulos GA.
    J Neurosurg Pediatr; 2014 Apr 05; 13(4):375-9. PubMed ID: 24559277
    [Abstract] [Full Text] [Related]

  • 20. Catecholamines in depression: a cumulative study of urinary norepinephrine and its major metabolites in unipolar and bipolar depressed patients versus healthy volunteers at the NIMH.
    Grossman F, Potter WZ.
    Psychiatry Res; 1999 Jul 30; 87(1):21-7. PubMed ID: 10512151
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.